5th “Headquarters for Securing Pharmaceuticals, Medical Devices, and Supplies Affected by the Middle East Situation”

News Highlights

On May 15, 2026, the 5th “Headquarters for Securing Pharmaceuticals, Medical Devices, and Supplies Affected by the Middle East Situation” was held. At this meeting, measures to address the risk of supply disruptions due to the escalating Middle East situation’s impact on the supply chains of pharmaceuticals, medical devices, and other essential supplies were discussed. Specifically, securing alternative procurement sources, increasing inventory levels, and strengthening support for domestic manufacturers were considered. The importance of a national-level crisis management system for securing essential supplies for the stable operation of medical institutions was re-emphasized.

M&A Medical Editorial Department’s Perspective

The impact of the escalating Middle East situation on the supply chains of pharmaceuticals and medical devices is an urgent issue directly linked to the business continuity planning (BCP) of medical institutions. In particular, many specific pharmaceuticals and advanced medical devices rely on imports from overseas, making geopolitical risks a direct threat of supply disruption. The establishment of this headquarters is not merely about securing supplies but can be seen as a sign that the government has begun to recognize the impact on the very経営基盤 (management foundation) of medical institutions. From an M&A perspective, such changes in the external environment can serve as an opportunity for medical institutions, especially those in specialties with high import dependency or those considering business succession due to a lack of successors, to review their business continuity plans, maintain or expand their business scale through M&A, or join a medical group with a stable business foundation. The vulnerability of supply chains can become a factor making independent business continuity difficult, thus increasing the need for strategic business succession.

Key Discussion Points from This News

• The government is specifically discussing the impact of the escalating Middle East situation on the supply chains of pharmaceuticals and medical devices through the “Headquarters for Securing Measures.”
• Geopolitical risks have the potential to directly impact the business continuity (BCP) of medical institutions, not just cause material shortages.
• For medical institutions with high import dependency, the vulnerability of their supply chains poses a risk of becoming a bottleneck for business continuity.
• Changes in the external environment may accelerate the consideration of business succession strategies (including M&A) for medical institutions.

Practical Questions Arising from This News

• Are there any pharmaceuticals or medical devices used at our institution that are particularly vulnerable to the Middle East situation?
• If procurement from overseas becomes difficult, are there alternative products or domestic suppliers available?
• As part of BCP measures, what level of inventory should be secured, and what are the associated costs?

If You Feel “Should I Consult?”

We recommend taking stock of where your institution’s pharmaceuticals and medical devices are sourced from and whether those procurement routes are stable. In particular, if there is reliance on specific countries or regions, geopolitical risks like those highlighted in this news could have a significant impact on the continuation of medical services. If you are considering business succession due to a lack of successors, this might be a good opportunity to consider joining a medical group with a more stable management foundation or exploring M&A schemes that can maintain your business scale, taking these external risks into account.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultations are available here.